Table 1.
Demographic, clinical, and biochemical characteristics in subjects with an abdominal aortic aneurysm (AAA) and control group.
| AAA (n = 36) | Control (n = 29) | p | ||
|---|---|---|---|---|
| Age (years) | 71 ± 8 | 63 ± 7 | 0.00009 | |
| Sex (male/female) | 27 (75)/9 (25) | 21 (69)/9 (31) | 0.589 | |
| Current smoker | 17 (47) | 18 (62) | 0.232 | |
| Diabetes mellitus | 7 (19) | 7 (24) | 0.647 | |
| Hypertension | 23 (64) | 17 (59) | 0.664 | |
| CVD | Myocardial infarction | 2 (6) | 6 (21) | 0.065 |
| Stroke | 2 (6) | 5 (17) | 0.131 | |
| DVT | 1 (3) | 1 (3) | 0.876 | |
| Statin therapy | 3 (8) | 8 (28) | 0.039 | |
| MPO (ng/mL) ‡ | 491 ± 183 | 601 ± 204 | 0.025 | |
| NGAL (ng/mL) | 190 (129–351) | 439 (242–733) | 0.001 | |
| Elastase (ng/mL) | 906 (535–1317) | 1237 (842–1865) | 0.045 | |
| IL-6 (pg/mL) | 40.0 (21.6–79.4) | 32.8 (16.8–58.3) | 0.229 | |
| TNF-a (pg/mL) | 0.001 (0.001–0.008) | 0.001 (0.001–0.004) | 0.443 | |
| AAA diameter ‡ | 59 ± 12 | |||
| ILT thickness ‡ | 32 ± 10 | |||
Unless indicated otherwise, values are data reported as arithmetic mean and 95% confidence intervals in parentheses or counts with percentages (categorical variables); ‡ mean ± standard deviation (continuous variables); CVD denotes cardiovascular disease; DVT—deep vein thrombosis; MPO—myeloperoxidase; NGAL—neutrophil gelatinase-associated lipocalin; IL-6—interleukin-6; TNF-a—tumour necrosis factor alpha.